Polyploidy-Inducing Compounds for Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatment methods, such as chemotherapy, radiation therapy, and surgery, have undesirable side effects and varying success rates, necessitating the development of new methods to effectively treat cancer and diseases associated with cellular proliferation.
Innovation Solution
Development of compounds of Formula (I), (II), and (III), or their pharmaceutically acceptable salts or N-oxides, which are used in pharmaceutical compositions to target and inhibit cancer cell proliferation, as demonstrated by their ability to induce polyploidy and suppress the growth of human cancer cell lines in vitro and in vivo.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemotherapy, radiation therapy, or surgery is used to treat cancer, then cancer cells are killed or removed, but undesirable side effects occur and success rates vary
Solution Approach 1:
The patent changes the fundamental parameter of cancer treatment from conventional methods (chemotherapy, radiation, surgery) to a novel chemical mechanism involving compounds that induce polyploidy and inhibit cell proliferation. This parameter change enables selective targeting of cancer cells while reducing harm to normal cells, thereby improving success rates and reducing side effects.
Solution Approach 2:
The patent replaces the mechanical/physical methods of cancer treatment (surgery, radiation) with a biochemical mechanism. The compounds work at the molecular level to disrupt cancer cell proliferation through polyploidy induction and cell cycle inhibition, substituting physical destruction with targeted biochemical action that is more reliable and less harmful.
2Productivity
If conventional cancer treatment methods are used, then treatment is administered, but varying success rates are achieved
Solution Approach 1:
The patent introduces novel chemical compounds with specific molecular structures (Formulas I, II, and III) that fundamentally change the treatment mechanism. These compounds consistently induce polyploidy and inhibit proliferation across different cancer cell lines, providing more reliable and consistent effectiveness compared to conventional treatments that vary in response to individual patient factors.
3Reliability
If new treatment methods are developed to improve efficacy, then cancer treatment effectiveness increases, but development complexity increases
Solution Approach 1:
The patent segments the complex task of cancer treatment development into manageable components: identifying active compounds (Formulas I, II, III), determining their mechanism of action (polyploidy induction), and validating efficacy through controlled in vitro and in vivo studies. This segmentation allows systematic development while maintaining high efficacy.
Solution Approach 2:
The patent uses well-established preclinical models (cell lines, animal models) as intermediaries to validate the treatment mechanism before human application. This intermediary approach allows rigorous testing of efficacy and safety in controlled environments, reducing the complexity and risk of direct human trial development.
Data Source
AI summary
The present disclose includes, among other things, compounds that treat or lessen the severity of a disorder, pharmaceutical compositions and methods of making and using the same.